(Q39936653)

15 September 2017

title

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort (English)

1 reference

15 September 2017

0 references

Esther Meijer

1

1 reference

15 September 2017

Stephan J L Bakker

2

1 reference

15 September 2017

Nynke Halbesma

3

1 reference

15 September 2017

Paul E de Jong

4

1 reference

15 September 2017

Joachim Struck

5

1 reference

15 September 2017

Ron T Gansevoort

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

77

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

29-36

1 reference

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Plasma and platelet vasopressin in essential hypertension and congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Copeptin: clinical use of a new biomarker

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Distribution, blood transport, and degradation of antidiuretic hormone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Water turnover in 458 American adults 40-79 yr of age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Microalbuminuria and risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Copeptin in the differential diagnosis of hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Urine electrolytes and the urine anion and osmolar gaps

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

What predicts progression and regression of urinary albumin excretion in the nondiabetic population?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.397

7 January 2021

Identifiers

DOI

10.1038/KI.2009.397

1 reference

15 September 2017

1 reference